drugset / Trial / NCT01692808

Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease

NCT01692808

Phase 2 Completed 20 enrolled St. Justine's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if high doses of vitamin D3 administered orally as adjunct therapy to children with Crohn's disease could improve the outcome of the disease.

Timeline

Start
2012-10
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 3000 iu Oral
Subject Cholecalciferol Other / unclassified 4000 iu Oral

Indications